Skip to content

Metabolic benefits of ketohexokinase inhibition in individuals with MASLD: a randomized placebo-controlled crossover trial.

Oct 2026 · Nature Metabolism · 1 citation · 43 references
Medicine
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.